These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2544665)

  • 1. Effects of acyclovir on herpes simplex virus type 1 infection in mice treated with 12-O-tetradecanoylphorbol 13-acetate.
    Larsson PA; Johansson SL; Hirsch JM; Vahlne A
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1773-8. PubMed ID: 2544665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response, recurrence patterns and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea-pigs: effects of acyclovir.
    Bernstein DI; Stanberry LR; Harrison CJ; Kappes JC; Myers MG
    J Gen Virol; 1986 Aug; 67 ( Pt 8)():1601-12. PubMed ID: 3016155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
    Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
    Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of herpetic lesions to malignancy by ultraviolet exposure and promoter application.
    Burns JC; Murray BK
    J Gen Virol; 1981 Aug; 55(Pt 2):305-13. PubMed ID: 6270265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients.
    Kim JH; Schaenman JM; Ho DY; Brown JM
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):259-64. PubMed ID: 20615475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empiric acyclovir for neonatal herpes simplex virus infection.
    Vanderpluym C; Tawfik G; Hervas-Malo M; Lacaze-Masmonteil T; Kellner J; Robinson JL
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1278-82. PubMed ID: 21992471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization.
    Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM
    J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
    Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
    J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir.
    Valerie K; Brust D; Farnsworth J; Amir C; Taher MM; Hershey C; Feden J
    Cancer Gene Ther; 2000 Jun; 7(6):879-84. PubMed ID: 10880018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
    Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
    J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease.
    Erard V; Wald A; Corey L; Leisenring WM; Boeckh M
    J Infect Dis; 2007 Jul; 196(2):266-70. PubMed ID: 17570114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic oral acyclovir in outbreaks of primary herpes simplex virus type 1 infection in a closed community.
    Kuzushima K; Kudo T; Kimura H; Kido S; Hanada N; Shibata M; Nishikawa K; Morishima T
    Pediatrics; 1992 Mar; 89(3):379-83. PubMed ID: 1311067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antiherpes virus activity of acyclovir and interferon in human corneal stromal cells.
    Taylor JL; Casey MS; O'Brien WJ
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):365-70. PubMed ID: 2466806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan.
    Hasegawa T; Kawana T; Okuda T; Horii M; Tsukada T; Shiraki K
    J Med Virol; 2001 Jan; 63(1):57-63. PubMed ID: 11130888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).
    Shiraki K; Miyaki C; Namazue J; Yamanishi K; Takahashi M
    Acta Virol; 1989 Dec; 33(6):565-8. PubMed ID: 2576598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined use of acyclovir and antibody in athymic nude mice inoculated intracutaneously with herpes simplex virus.
    Yamamoto M; Hayashi Y; Tang LL; Mori R
    Antiviral Res; 1985 Apr; 5(2):83-91. PubMed ID: 2990334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    Virology; 1999 Sep; 262(1):230-6. PubMed ID: 10489356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soft-tissue tumours induced in Syrian hamsters by herpes simplex virus type 1 and a chemical promoter.
    Hadjiolov D; Hadjiolov N; zur Hausen H
    J Cancer Res Clin Oncol; 1993; 119(6):309-11. PubMed ID: 8383686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.